Your browser doesn't support javascript.
loading
Automatic Assessment of the 2-Minute Walk Distance for Remote Monitoring of People with Multiple Sclerosis.
Kontaxis, Spyridon; Laporta, Estela; Garcia, Esther; Martinis, Matteo; Leocani, Letizia; Roselli, Lucia; Buron, Mathias Due; Guerrero, Ana Isabel; Zabala, Ana; Cummins, Nicholas; Vairavan, Srinivasan; Hotopf, Matthew; Dobson, Richard J B; Narayan, Vaibhav A; La Porta, Maria Libera; Costa, Gloria Dalla; Magyari, Melinda; Sørensen, Per Soelberg; Nos, Carlos; Bailon, Raquel; Comi, Giancarlo.
Afiliação
  • Kontaxis S; Laboratory of Biomedical Signal Interpretation and Computational Simulation (BSICoS), University of Zaragoza, 50018 Zaragoza, Spain.
  • Laporta E; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 28006 Barcelona, Spain.
  • Garcia E; Laboratory of Biomedical Signal Interpretation and Computational Simulation (BSICoS), University of Zaragoza, 50018 Zaragoza, Spain.
  • Martinis M; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 28006 Barcelona, Spain.
  • Leocani L; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 28006 Barcelona, Spain.
  • Roselli L; Department of Microelectronics and Electronic Systems, Autonomous University of Barcelona, 08193 Bellaterra, Spain.
  • Buron MD; Department of Medicine and Surgery, University Vita-Salute and Hospital San Raffaele, 20132 Milan, Italy.
  • Guerrero AI; Department of Medicine and Surgery, University Vita-Salute and Hospital San Raffaele, 20132 Milan, Italy.
  • Zabala A; Department of Medicine and Surgery, University Vita-Salute and Hospital San Raffaele, 20132 Milan, Italy.
  • Cummins N; Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital Rigshospitalet, 2100 Copenhagen, Denmark.
  • Vairavan S; Multiple Sclerosis Center of Catalonia (CEMCAT), Department of Neurology/Neuroimmunology, Hospital Universitari Vall d'Hebron, Universitat Autonoma de Barcelona, 08035 Barcelona, Spain.
  • Hotopf M; Multiple Sclerosis Center of Catalonia (CEMCAT), Department of Neurology/Neuroimmunology, Hospital Universitari Vall d'Hebron, Universitat Autonoma de Barcelona, 08035 Barcelona, Spain.
  • Dobson RJB; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK.
  • Narayan VA; Janssen Research and Development, LLC, Titusville, NJ 08560, USA.
  • La Porta ML; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK.
  • Costa GD; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK.
  • Magyari M; Institute of Health Informatics, University College London, London NW1 2DA, UK.
  • Sørensen PS; Davos Alzheimer's Collaborative, Wayne, PA 19087, USA.
  • Nos C; Department of Medicine and Surgery, University Vita-Salute and Hospital San Raffaele, 20132 Milan, Italy.
  • Bailon R; Department of Medicine and Surgery, University Vita-Salute and Hospital San Raffaele, 20132 Milan, Italy.
  • Comi G; Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital Rigshospitalet, 2100 Copenhagen, Denmark.
  • On Behalf Of The Radar-Cns Consortium; Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital Rigshospitalet, 2100 Copenhagen, Denmark.
Sensors (Basel) ; 23(13)2023 Jun 29.
Article em En | MEDLINE | ID: mdl-37447866
The aim of this study was to investigate the feasibility of automatically assessing the 2-Minute Walk Distance (2MWD) for monitoring people with multiple sclerosis (pwMS). For 154 pwMS, MS-related clinical outcomes as well as the 2MWDs as evaluated by clinicians and derived from accelerometer data were collected from a total of 323 periodic clinical visits. Accelerometer data from a wearable device during 100 home-based 2MWD assessments were also acquired. The error in estimating the 2MWD was validated for walk tests performed at hospital, and then the correlation (r) between clinical outcomes and home-based 2MWD assessments was evaluated. Robust performance in estimating the 2MWD from the wearable device was obtained, yielding an error of less than 10% in about two-thirds of clinical visits. Correlation analysis showed that there is a strong association between the actual and the estimated 2MWD obtained either at hospital (r = 0.71) or at home (r = 0.58). Furthermore, the estimated 2MWD exhibits moderate-to-strong correlation with various MS-related clinical outcomes, including disability and fatigue severity scores. Automatic assessment of the 2MWD in pwMS is feasible with the usage of a consumer-friendly wearable device in clinical and non-clinical settings. Wearable devices can also enhance the assessment of MS-related clinical outcomes.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article